Meeder Asset Management Inc Astrazeneca PLC Transaction History

Meeder Asset Management Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $5,567 - $14,253	105 Added 5.5%	2,015 $111,000
Q2 2022 Aug 08, 2022	SELL	$59.26 - $71.14 $35,911 - $43,110	-606 Reduced 24.09%	1,910 $126,000
Q1 2022 May 10, 2022	BUY	$55.72 - $67.12 $140,191 - $168,873	2,516 New	2,516 $167,000
Q4 2021 Feb 11, 2022	SELL	$54.02 - $63.83 $177,833 - $210,128	-3,292 Closed	0 $0
Q3 2021 Nov 08, 2021	BUY	$55.56 - $60.79 $160,457 - $175,561	2,888 Added 714.85%	3,292 $198,000
Q2 2021 Aug 09, 2021	BUY	$48.42 - $60.18 $18,738 - $23,289	387 Added 2276.47%	404 $24,000
Q3 2020 Nov 02, 2020	BUY	$53.07 - $61.1 $902 - $1,038	17 New	17 $1,000
Q3 2019 Oct 17, 2019	SELL	$40.12 - $45.47 $75,786 - $85,892	-1,889 Closed	0 $0
Q2 2019 Aug 05, 2019	BUY	$37.28 - $41.68 $70,421 - $78,733	1,889 New	1,889 $78,000
Q4 2017 Feb 02, 2018	SELL	$32.09 - $34.78 $98,805 - $107,087	-3,079 Closed	0 $0
Q3 2017 Oct 20, 2017	BUY	$28.96 - $34.0 $89,167 - $104,686	3,079	3,079 $104,000

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.